[HTML][HTML] COVID-19-associated acute respiratory distress syndrome (CARDS): Current knowledge on pathophysiology and ICU treatment–A narrative review

CA Pfortmueller, T Spinetti, RD Urman… - Best Practice & …, 2021 - Elsevier
Abstract (163 words) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
induces coronavirus-19 disease (COVID-19) and is a major health concern. Following two …

[HTML][HTML] Glutathione: A Samsonian life-sustaining small molecule that protects against oxidative stress, ageing and damaging inflammation

CA Labarrere, GS Kassab - Frontiers in Nutrition, 2022 - frontiersin.org
Many local and systemic diseases especially diseases that are leading causes of death
globally like chronic obstructive pulmonary disease, atherosclerosis with ischemic heart …

Systemic inflammation and COVID-19 mortality in patients with major noncommunicable diseases: chronic coronary syndromes, diabetes and obesity

AL Buicu, S Cernea, I Benedek, CF Buicu… - Journal of Clinical …, 2021 - mdpi.com
COVID-19 is currently considered an inflammatory disease affecting the entire organism. In
severe forms, an augmented inflammatory response leads to the fulminant “cytokine storm” …

The effect of statins on clinical outcome among hospitalized patients with COVID-19: a multi-centric cohort study

S Umakanthan, S Senthil, S John… - Frontiers in …, 2022 - frontiersin.org
The coronavirus disease-2019 (COVID-19) is caused by SARS-CoV-2, leading to acute
respiratory distress syndrome (ARDS), thrombotic complications, and myocardial injury …

[HTML][HTML] Possible mechanisms of cholesterol elevation aggravating COVID-19

Y Tang, L Hu, Y Liu, B Zhou, X Qin, J Ye… - … journal of medical …, 2021 - ncbi.nlm.nih.gov
Importance: Despite the availability of a vaccine against the severe acute respiratory
syndrome-coronavirus-2 (SARS-CoV-2), humans will have to live with this virus and the after …

Distinct features of vascular diseases in COVID-19

A Ceasovschih, V Sorodoc, A Shor… - Journal of …, 2023 - Taylor & Francis
Abstract The Coronavirus Disease 2019 (COVID-19) pandemic was declared in early 2020
after several unexplained pneumonia cases were first reported in Wuhan, China, and …

Glycemic control and clinical outcomes in US patients with COVID-19: data from the National COVID Cohort Collaborative (N3C) database

R Wong, M Hall, R Vaddavalli, A Anand, N Arora… - Diabetes …, 2022 - Am Diabetes Assoc
OBJECTIVE The purpose of the study is to evaluate the relationship between HbA1c and
severity of coronavirus disease 2019 (COVID-19) outcomes in patients with type 2 diabetes …

Atherosclerosis, cardiovascular disease, and COVID-19: a narrative review

C Vilaplana-Carnerero, M Giner-Soriano, À Dominguez… - Biomedicines, 2023 - mdpi.com
Atherosclerosis is a chronic inflammatory and degenerative process that mainly occurs in
large-and medium-sized arteries and is morphologically characterized by asymmetric focal …

Atherosclerosis, cardiovascular disorders and COVID-19: Comorbid pathogenesis

YA Makarova, VA Ryabkova, VV Salukhov, BV Sagun… - Diagnostics, 2023 - mdpi.com
The article describes how atherosclerosis and coronavirus disease 19 (COVID-19) may
affect each other. The features of this comorbid pathogenesis at various levels (vascular …

The potential impact of COVID-19 virus on the heart and the circulatory system

MS Alqahtani, M Abbas, A Alsabaani… - Infection and Drug …, 2022 - Taylor & Francis
Heart attacks, arrhythmias, and cardiomyopathy are all linked to the 2019 coronavirus
disease (COVID-19), which has been identified as a risk factor for cardiovascular disease …